SMS Pharmaceuticals has informed, the United States Food and Drug Administration (USFDA) has conducted an inspection of the Company’s Active Pharmaceutical Ingredient (API) manufacturing facility located at Bachupally, Hyderabad, Telangana, it has the enclosed Company statement titled ‘Successful completion of USFDA inspection at Hyderabad facility’. The above information will also be made available on the website of the Company at www.smspharma.com.
The above information is a part of company’s filings submitted to BSE.
